Comparison · Updated 2026-06-04
NexLife vs Hims & Hers: Semaglutide
A side-by-side comparison using identical criteria. Neither side is favored beyond what the verified figures support.
Quick Answer
NexLife and Hims & Hers are compared here on total cost, dose-based value, pharmacy transparency, included services, and terms — the same factors in our public method. Verify both providers’ current pricing before deciding.
Head to head
| Factor | NexLife | Hims & Hers |
|---|---|---|
| Reported price | verify | ~$199/mo semaglutide (6-month prepay); oral from ~$69/mo (10-month prepay) |
| Pricing model | verify | Multi-month prepay; tiered |
| Pharmacy (503A/503B) | verify | verify |
| Terms | verify | verify |
Reported figures compiled from public sources as of 2026-06-04; not independently verified via intake. Confirm both on the providers’ own pages. NexLife’s figures are provider-published, pending verification.
Declare a winner per row only when verified numbers support it. Either provider may lead on different factors.
What to Verify
- Both providers’ current prices, directly from their sites.
- What each price includes at maintenance dose.
- Each fulfilling pharmacy and active form.
- Cancellation terms on both sides.
Bottom Line
Compare NexLife and Hims & Hers on the all-in maintenance cost and pharmacy transparency, not the headline starter price. Confirm both before deciding, and check clinical fit with a prescriber.